Kamada Ltd. — Report Publication Announcement 2017

Jun 22, 2017

_________ false

����� ��"�	2 380
KAMADA LTD
Corporation no: 511524605	10991
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		C002 ( Public )		Reported via MAGNA:	22/06/2017
	www.isa.gov.il			www.tase.co.il				Reference:	2017-02-052384	Time of broadcast: 13:54 13:53:06

---

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on Kamada Announces Withdrawal of European Marketing Authorization Application for Inhaled Alpha-1-Antitrypsin for Treatment of Alpha-1 Antitrypsin Deficiency Disease
FINAL_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: -1	Date of revision of form structure: 19/06/2017
Address: Sapir 7 P.O.B 4081 , Ness-Ziona 74036   ISRAEL , Tel: 08-9406472 , Fax: 08-9406473
E-mail address: liatc@kamada.com   Company site: www.kamada.com
Previous names of reporting entity:
Name of the Signatory: Fhima Lior Position of Signatory in the reporting corporation: Director of Finance Name of Employer Company:
Address: Sapir 7 , Ness Ziona 7403630 Telephone: 08-9913168 Facsimile: 08-9912083 E-mail: liorf@kamada.com 2